Results 91 to 100 of about 7,307 (207)

EPHX2 Orchestrates Intestinal Epithelial Barrier Repair in Ulcerative Colitis: An Integrated Multi‐Omics and Experimental Study

open access: yesClinical and Translational Science, Volume 19, Issue 7, July 2026.
This study employed an integrated multi‐omics screening strategy incorporating GEO database differential expression analysis, GWAS‐eQTL genetic association analysis, and single‐cell RNA‐seq cell subpopulation localization to identify EPHX2 as a core causal gene in ulcerative colitis (UC).
Tian Dai   +8 more
wiley   +1 more source

Supplementary information Novel Soluble Epoxide Hydrolase Inhibitor: Toward Regulatory Preclinical Studies [PDF]

open access: yes
Neuroinflammation is widely recognized as a key pathological hallmark of Alzheimer’s disease (AD). Recently, inhibiting soluble epoxide hydrolase (sEH) has emerged as a promising therapeutic strategy for AD.
Sanfeliu, Coral   +9 more
core   +1 more source

Integrated transcriptome–metabolome analyses reveal regulatory networks underlying soluble solids accumulation in Capsicum chinense fruits

open access: yesThe Plant Journal, Volume 127, Issue 1, July 2026.
SUMMARY The Capsicum genus shows remarkable phenotypic diversity, making it an excellent system to study non‐climacteric fruit ripening. Unlike climacteric model species, such as tomato (Solanum lycopersicum), the regulatory networks linking transcriptome and metabolome to fruit quality traits remain poorly understood in non‐climacteric crop species ...
Wesley Elias Bhering Barrios   +12 more
wiley   +1 more source

Insights into the potential role of sEH inhibition in the prevention and progression of neurological disorders

open access: yesEndocrine and Metabolic Science
Neurological disorders are associated with decreased blood supply to the brain, neuronal damage, oxidative stress, and inflammation. While treatments are limited, soluble epoxide hydrolase inhibitors can be useful in alleviating neurological disorders ...
Mamatha Gavisiddaiah   +7 more
doaj   +1 more source

Liver Soluble Epoxide Hydrolase Regulates Behavioral and Cellular Effects of Chronic Stress

open access: yesCell Reports, 2019
Summary: Major depression is a serious global health concern; however, the pathophysiology underlying this condition remains unclear. While numerous studies have focused on brain-specific mechanisms, few have evaluated the role of peripheral organs in ...
Xi-He Qin   +11 more
doaj   +1 more source

Supplementary Data from Sorafenib has soluble epoxide hydrolase inhibitory activity, which contributes to its effect profile in vivo [PDF]

open access: yes, 2009
Supplementary Data from Sorafenib has soluble epoxide hydrolase inhibitory activity, which contributes to its effect profile in ...
Bruce D. Hammock (65754)   +5 more
core   +1 more source

Soluble Epoxide Hydrolase Inhibitor: A Novel Potential Therapeutic or Prophylactic Drug for Psychiatric Disorders

open access: yesFrontiers in Pharmacology, 2019
Psychiatric disorders, including depression and schizophrenia, affect millions of individuals worldwide. However, the precise neurobiology of psychiatric disorders remains unclear. Accumulating evidence suggests that various inflammatory processes play a
Qian Ren, Qian Ren
doaj   +1 more source

Soluble Epoxide Hydrolase Inhibition Protected against Angiotensin II-induced Adventitial Remodeling

open access: yesScientific Reports, 2017
Epoxyeicosatrienoic acids (EETs), the metabolites of cytochrome P450 epoxygenases derived from arachidonic acid, exert important biological activities in maintaining cardiovascular homeostasis.
Chi Zhou   +5 more
doaj   +1 more source

Regulation of the soluble epoxide hydrolase by peroxynitrite

open access: yesThe FASEB Journal, 2008
Inhibition of the soluble epoxide hydrolase (sEH), which for example converts epoxyeicosatrienoic acids to dihydroxyeicosatrienoic acids (DHETs), has anti‐inflammatory as well as anti‐hypertensive effects. As the enzymatic core of the sEH hydrolase domain contains two tyrosine residues (Tyr383 & 466), we addressed the hypothesis that the activity ...
Eduardo Barbosa‐Sicard   +3 more
openaire   +1 more source

The Emerging Parkinson's Disease Oxylipin‐Ome

open access: yesAdvanced Science, Volume 13, Issue 33, 15 June 2026.
ABSTRACT Parkinson Disease (PD) is increasingly considered a proteinopathy and lipidopathy. This proteinopathy+lipidopathy paradigm has been further refined to a fatty acid (FA)‐opathy, centering dysregulated FA metabolism as fundamental in PD lipid dysfunction.
Julia C. Kelliher, Saranna Fanning
wiley   +1 more source

Home - About - Disclaimer - Privacy